Ting Luo Selected Research

Ting Luo Research Topics

Disease

82	Neoplasms (Cancer) 02/2024 - 01/2006
55	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2007
22	Inflammation (Inflammations) 01/2024 - 01/2016
15	Body Weight (Weight, Body) 03/2024 - 11/2006
15	Neoplasm Metastasis (Metastasis) 12/2023 - 03/2005
11	Obesity 04/2023 - 01/2013
10	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 11/2011
9	Dysbiosis 11/2021 - 01/2017
8	Carcinogenesis 12/2023 - 01/2007
8	Hyperaldosteronism (Conn Syndrome) 10/2022 - 01/2018
7	Infections 01/2023 - 01/2016
6	Insulin Resistance 01/2022 - 01/2013
6	Carcinoma (Carcinomatosis) 11/2017 - 03/2005
5	Non-alcoholic Fatty Liver Disease 04/2024 - 09/2022
5	Hypertension (High Blood Pressure) 01/2023 - 01/2020
5	Atherosclerosis 01/2023 - 05/2012
5	Colitis 10/2022 - 07/2020
5	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2016
5	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 04/2013
5	Stomach Neoplasms (Stomach Cancer) 01/2008 - 03/2005
4	Lung Neoplasms (Lung Cancer) 12/2023 - 06/2012
4	Fibrosis (Cirrhosis) 12/2023 - 01/2016
4	COVID-19 03/2023 - 01/2020
4	Pneumonia (Pneumonitis) 02/2023 - 01/2022
4	Hyperuricemia 01/2023 - 02/2013
4	Wounds and Injuries (Trauma) 01/2022 - 02/2019
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2018
4	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2017
4	Adenocarcinoma of Lung 01/2022 - 11/2019
4	Type 2 Diabetes Mellitus (MODY) 10/2021 - 01/2017
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2020 - 10/2016
4	Mycoses (Diseases, Fungus) 12/2018 - 12/2015
3	Triple Negative Breast Neoplasms 01/2024 - 01/2022
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2023 - 02/2023
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 06/2017
3	Hyperlipidemias (Hyperlipidemia) 04/2023 - 12/2018
3	Atrophy 01/2023 - 12/2020
3	Adenoma (Adenomas) 10/2022 - 03/2016

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2005
16	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2005
9	LipidsIBA 03/2024 - 10/2016
9	pyrotinibIBA 12/2023 - 01/2021
9	Trastuzumab (Herceptin)FDA Link 10/2023 - 01/2020
8	Hormones (Hormone)IBA 12/2023 - 11/2021
8	ErbB Receptors (EGF Receptor)IBA 12/2023 - 01/2015
8	Messenger RNA (mRNA)IBA 12/2023 - 01/2006
8	Triglycerides (Triacylglycerol)IBA 04/2023 - 12/2018
8	AldosteroneIBA 10/2022 - 01/2018
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2011
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 09/2009
6	human ERBB2 proteinIBA 02/2024 - 01/2021
6	CholesterolIBA 04/2023 - 01/2020
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
5	CytokinesIBA 01/2024 - 02/2021
5	Long Noncoding RNAIBA 01/2022 - 08/2017
5	Endoplasmic Reticulum Chaperone BiPIBA 05/2018 - 09/2009
4	AntioxidantsIBA 04/2024 - 05/2012
4	Small Interfering RNA (siRNA)IBA 04/2024 - 03/2009
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2021
4	Estrogen ReceptorsIBA 11/2023 - 12/2021
4	C-Reactive ProteinIBA 07/2023 - 01/2020
4	Hemoglobins (Hemoglobin)IBA 07/2023 - 01/2022
4	AlbuminsIBA 01/2023 - 01/2018
4	Uric Acid (Urate)IBA 01/2023 - 02/2013
4	Dextran SulfateIBA 05/2022 - 07/2020
4	ReninIBA 12/2021 - 01/2018
4	CateninsIBA 11/2021 - 09/2014
4	Lapatinib (GW572016)FDA Link 01/2021 - 01/2020
4	Polysaccharides (Glycans)IBA 12/2020 - 01/2018
4	bisphenol AIBA 02/2019 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 01/2012
4	PolyphenolsIBA 01/2016 - 01/2010
4	Caspase 7IBA 09/2013 - 03/2009
3	EnzymesIBA 01/2024 - 06/2007
3	Competitive Endogenous RNAIBA 01/2024 - 08/2017
3	Glycoproteins (Glycoprotein)IBA 01/2024 - 01/2020
3	VaccinesIBA 12/2023 - 01/2022
3	EstersIBA 12/2023 - 03/2014
3	ginsenoside Rh2IBA 12/2023 - 12/2021
3	Interleukin-17 (Interleukin 17)IBA 12/2023 - 01/2023
3	CollagenIBA 12/2023 - 01/2016
3	Bleomycin (Blenoxane)FDA LinkGeneric 12/2023 - 02/2023
3	Progesterone Receptors (Progesterone Receptor)IBA 07/2023 - 01/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2023 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2023 - 12/2019
3	oxidized low density lipoproteinIBA 01/2023 - 05/2014
3	Epidermal Growth Factor (EGF)IBA 01/2023 - 11/2020
3	fibroblast growth factor 21IBA 01/2023 - 01/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 05/2012
3	taxaneIBA 01/2023 - 09/2009
3	CreatinineIBA 01/2023 - 01/2018
3	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2021
3	Retinaldehyde (Retinal)IBA 01/2023 - 01/2017
3	MTOR InhibitorsIBA 12/2022 - 01/2015
3	Polystyrenes (Polystyrene)IBA 10/2022 - 08/2018

Therapy/Procedure

40	Therapeutics 02/2024 - 11/2009
24	Drug Therapy (Chemotherapy) 01/2024 - 01/2007
13	Radiotherapy 01/2023 - 01/2007
7	Neoadjuvant Therapy 01/2023 - 03/2017
3	Immunotherapy 01/2023 - 10/2016